Published in Aust N Z J Psychiatry on April 03, 2012
Manic exacerbation induced by nicotine patch. Aust N Z J Psychiatry (2012) 1.41
Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy. Addiction (2009) 2.64
Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause (2006) 2.07
Women survivors of child abuse - don't ask, don't tell. Aust Fam Physician (2012) 2.01
Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA (2012) 1.90
Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry (2008) 1.78
An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Res (2006) 1.53
Clinical outcomes associated with depression, anxiety and social support among cardiac rehabilitation attendees. Aust N Z J Psychiatry (2010) 1.53
Funding for mental health research: the gap remains. Med J Aust (2011) 1.38
Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment (2012) 1.37
Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry (2003) 1.36
Clinician-assisted computerised versus therapist-delivered treatment for depressive and addictive disorders: a randomised controlled trial. Med J Aust (2011) 1.30
An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend (2010) 1.28
A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology (2009) 1.16
Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab (2007) 1.14
A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry (2006) 1.13
Pilot randomized controlled trial of a brief alcohol intervention group for adolescents. Drug Alcohol Rev (2004) 1.09
A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain Behav Immun (2012) 1.09
A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression. Int J Neuropsychopharmacol (2006) 1.08
An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder. Hum Brain Mapp (2008) 1.07
Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics. Aust N Z J Psychiatry (2007) 1.06
A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. J Clin Psychopharmacol (2005) 1.02
A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder. Compr Psychiatry (2010) 0.98
Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction (2012) 0.97
A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia. Psychiatry Res (2002) 0.97
Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study. Addiction (2014) 0.96
What is needed to deliver collaborative care to address comorbidity more effectively for adults with a severe mental illness? Aust N Z J Psychiatry (2012) 0.94
Reasons for substance use among people with mental disorders. Addict Behav (2011) 0.93
Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatry (2013) 0.92
Reduced neural activity of the prefrontal cognitive control circuitry during response inhibition to negative words in people with schizophrenia. J Psychiatry Neurosci (2012) 0.91
Naturalistic study of the use of transcranial magnetic stimulation in the treatment of depressive relapse. Aust N Z J Psychiatry (2006) 0.91
Associations between alcohol, smoking, socioeconomic status and comorbidities: evidence from the 45 and Up Study. Drug Alcohol Rev (2013) 0.90
A longitudinal study of patient- and observer-rated quality of life in schizophrenia. Psychiatry Res (2003) 0.90
The 'co-morbidity roundabout': a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems. Drug Alcohol Rev (2004) 0.89
Estrogens and gonadal function in schizophrenia and related psychoses. Curr Top Behav Neurosci (2011) 0.88
Coronary heart disease risk reduction intervention among overweight smokers with a psychotic disorder: pilot trial. Aust N Z J Psychiatry (2009) 0.87
A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimul (2007) 0.86
A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression. Depress Anxiety (2009) 0.86
Transitioning patients taking clozapine from the public to private/GP shared-care setting: barriers and criteria. Aust N Z J Psychiatry (2012) 0.85
Prevalence of smoking and other health risk factors in people attending residential substance abuse treatment. Drug Alcohol Rev (2012) 0.85
Motor cortical excitability and clinical response to rTMS in depression. J Affect Disord (2004) 0.85
A preliminary fMRI study of the effects on cortical activation of the treatment of refractory auditory hallucinations with rTMS. Psychiatry Res (2007) 0.84
Study protocol: a dissemination trial of computerized psychological treatment for depression and alcohol/other drug use comorbidity in an Australian clinical service. BMC Psychiatry (2012) 0.84
The treatment of recurring auditory hallucinations in schizophrenia with rTMS. World J Biol Psychiatry (2006) 0.84
Vestibular insights into cognition and psychiatry. Brain Res (2013) 0.83
Demonstrating the effectiveness of less restrictive care pathways for the management of patients treated with clozapine. Australas Psychiatry (2013) 0.83
A transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia. Psychiatry Res (2003) 0.82
Priming stimulation enhances the effectiveness of low-frequency right prefrontal cortex transcranial magnetic stimulation in major depression. J Clin Psychopharmacol (2008) 0.82
Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders. Addict Behav (2013) 0.81
A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression. J Clin Psychopharmacol (2007) 0.81
Reasons for substance use among people with psychotic disorders: method triangulation approach. Psychol Addict Behav (2011) 0.81
Gender-sensitive mental health care. Australas Psychiatry (2009) 0.81
The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain. Hum Psychopharmacol (2003) 0.81
BraveHeart begins: pilot results of group cognitive behaviour therapy for depression and anxiety in cardiac patients. Aust N Z J Psychiatry (2009) 0.81
Amoxapine in schizophrenia: a negative double-blind controlled trial. J Clin Psychopharmacol (2004) 0.81
The sick role, illness cognitions and outcomes in bipolar disorder. J Affect Disord (2012) 0.81
Estradiol treatment and its interaction with the cholinergic system: effects on cognitive function in healthy young women. Horm Behav (2008) 0.81
Exposure to dysfunctional parenting and trauma events and posttraumatic stress profiles among a treatment sample with coexisting depression and alcohol use problems. Drug Alcohol Rev (2011) 0.80
The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia. Schizophr Res Treatment (2012) 0.80
EVestG: a diagnostic measure for schizophrenia. Conf Proc IEEE Eng Med Biol Soc (2008) 0.80
A study of the effects of lorazepam and dextromethorphan on the response to cortical 1 Hz repetitive transcranial magnetic stimulation. Neuroreport (2005) 0.80
The influence of depression on treatment for methamphetamine use. Med J Aust (2011) 0.80
Craving as a predictor of treatment outcomes in heavy drinkers with comorbid depressed mood. Addict Behav (2012) 0.80
Neurocognitive profiles of people with comorbid depression and alcohol use: implications for psychological interventions. Addict Behav (2009) 0.80
Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS Drugs (2007) 0.80
Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia. Drug Alcohol Rev (2012) 0.80
Vulnerable populations and multicentred research. Int J Ment Health Nurs (2009) 0.79
Testosterone improves antidepressant-emergent loss of libido in women: findings from a randomized, double-blind, placebo-controlled trial. J Sex Med (2014) 0.79
Integrating and extending cohort studies: lessons from the eXtending Treatments, Education and Networks in Depression (xTEND) study. BMC Med Res Methodol (2013) 0.79
What factors determine whether a woman becomes depressed during the perimenopause? Arch Womens Ment Health (2012) 0.78
Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial. Menopause (2006) 0.78
A study of the effectiveness of high-frequency left prefrontal cortex transcranial magnetic stimulation in major depression in patients who have not responded to right-sided stimulation. Psychiatry Res (2009) 0.78
A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study. Can J Psychiatry (2009) 0.78
No Relationship Between Binocular Rivalry Rate and Eye-Movement Profiles in Healthy Individuals: A Bayes Factor Analysis. Perception (2015) 0.77
Investigation of a Suicide Ideation Risk Profile in People With Co-occurring Depression and Substance Use Disorder. J Nerv Ment Dis (2016) 0.77
The role of inflammatory markers in explaining the association between depression and cardiovascular hospitalisations. J Behav Med (2015) 0.77
Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific survey. Neuropsychiatr Dis Treat (2013) 0.77
Depressive, positive, negative and parkinsonian symptomsin schizophrenia. Aust N Z J Psychiatry (2002) 0.77
The perceived risks and benefits of quitting in smokers diagnosed with severe mental illness participating in a smoking cessation intervention: gender differences and comparison to smokers without mental illness. Drug Alcohol Rev (2013) 0.77
A randomised controlled trial linking mental health inpatients to community smoking cessation supports: a study protocol. BMC Public Health (2011) 0.77
Factors associated with depression during the perimenopausal transition. Womens Health Issues (2013) 0.77
Managing psychosis in pregnancy. Aust N Z J Psychiatry (2007) 0.76
Hormonal therapies for new onset and relapsed depression during perimenopause. Maturitas (2012) 0.76
Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders. Ann Clin Psychiatry (2012) 0.76
Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: outcomes. Aust N Z J Psychiatry (2007) 0.76
Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response? Int J Neuropsychopharmacol (2010) 0.76
Stepping through treatment: reflections on an adaptive treatment strategy among methamphetamine users with depression. Drug Alcohol Rev (2010) 0.76
Sensitivity, specificity, and predictive power of the "Brief Risk-resilience Index for SCreening," a brief pan-diagnostic web screen for emotional health. Brain Behav (2012) 0.76
Breastfeeding and psychotropic medications. Lancet (2013) 0.76
Sequential behavioral treatment of smoking and weight control in bipolar disorder. Transl Behav Med (2012) 0.76
Incidental treatment effects of CBT on suicidal ideation and hopelessness. J Affect Disord (2013) 0.76
Primary healthcare practitioners' screening practices and attitudes towards women survivors of child abuse. Ment Health Fam Med (2012) 0.75
Psychometric properties of a scale to measure investment in the sick role: the Illness Cognitions Scale. J Eval Clin Pract (2010) 0.75
Study protocol: a randomized controlled trial of a computer-based depression and substance abuse intervention for people attending residential substance abuse treatment. BMC Public Health (2012) 0.75
Raloxifene may have further benefits in women on hemodialysis. Int J Endocrinol Metab (2012) 0.75
Psychotropic medication in pregnancy. Med J Aust (2013) 0.75